Use of Angiotensin II for Vasoplegic Shock in a Combined Heart and Liver Transplant Recipient with Systolic Anterior Motion Physiology
We report our use of angiotensin II infusion for vasoplegic shock in a combined heart and liver transplantation recipient with hypertrophic cardiomyopathy and systolic anterior motion of the mitral leaflet (SAM). A 34-year-old woman (60 kg) with complex congenital heart disease, failing Fontan physiology dependent on pharmacologic inotropy, and cardiac cirrhosis underwent combined orthotopic heart and deceased-donor liver transplantation. The cause of death in the donor was aneurysmal subarachnoid hemorrhage.
Source: Journal of Cardiothoracic and Vascular Anesthesia - Category: Anesthesiology Authors: Patrick M. Wieruszewski, Charles R. Sims, Richard C. Daly, Timucin Taner, Erica D. Wittwer Tags: Letter to the Editor Source Type: research
More News: Anesthesia | Anesthesiology | Cardiology | Cardiomyopathy | Cirrhosis | Heart | Heart Disease | Heart Transplant | Hypertrophic Cardiomyopathy | Liver | Liver Transplant | Physiology | Subarachnoid Hemorrhage | Transplant Surgery | Transplants | Urology & Nephrology